165 related articles for article (PubMed ID: 32750728)
1. Serum biomarkers in patients with stable and exacerbated COPD-bronchiectasis overlap syndrome.
Sever ZK; Bircan HA; Sirin FB; Evrimler S; Celik S; Merd N
Clin Respir J; 2020 Nov; 14(11):1032-1039. PubMed ID: 32750728
[TBL] [Abstract][Full Text] [Related]
2. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD.
Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U
Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430
[TBL] [Abstract][Full Text] [Related]
3. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
4. Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography.
Tulek B; Kivrak AS; Ozbek S; Kanat F; Suerdem M
Can Respir J; 2013; 20(2):91-6. PubMed ID: 23616965
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease.
Jin J; Yu W; Li S; Lu L; Liu X; Sun Y
Medicine (Baltimore); 2016 Jul; 95(29):e4219. PubMed ID: 27442646
[TBL] [Abstract][Full Text] [Related]
6. The Bronchiectasis in COPD-OSA Overlap Syndrome Patients.
Yang X; Tang X; Cao Y; Dong L; Wang Y; Zhang J; Cao J
Int J Chron Obstruct Pulmon Dis; 2020; 15():605-611. PubMed ID: 32256061
[TBL] [Abstract][Full Text] [Related]
7. Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.
Böcskei RM; Benczúr B; Losonczy G; Illyés M; Cziráki A; Müller V; Bohács A; Bikov A
Lung; 2019 Apr; 197(2):189-197. PubMed ID: 30820636
[TBL] [Abstract][Full Text] [Related]
8. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.
Gompertz S; Bayley DL; Hill SL; Stockley RA
Thorax; 2001 Jan; 56(1):36-41. PubMed ID: 11120902
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
Kawamatawong T; Onnipa J; Suwatanapongched T
Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
[TBL] [Abstract][Full Text] [Related]
10. Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD.
Godtfredsen NS; Jørgensen DV; Marsaa K; Ulrik CS; Andersen O; Eugen-Olsen J; Rasmussen LJH
Respir Res; 2018 May; 19(1):97. PubMed ID: 29783959
[TBL] [Abstract][Full Text] [Related]
11. Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD.
AboEl-Magd GH; Mabrouk MM
J Bras Pneumol; 2018; 44(1):36-41. PubMed ID: 29538541
[TBL] [Abstract][Full Text] [Related]
12. The effect of bronchiectasis on the exacerbation and mortality of chronic obstructive pulmonary disease.
Fendoğlu TZ; Köktürk N; Yapar D; Kılıç P; Kılıç K; Erbaş G
Clin Respir J; 2021 Oct; 15(10):1113-1120. PubMed ID: 34224649
[TBL] [Abstract][Full Text] [Related]
13. The role of serum soluble urokinase-type plasminogen activator receptor in stable chronic obstructive pulmonary disease.
Can Ü; Güzelant A; Yerlikaya FH; Yosunkaya Ş
J Investig Med; 2014 Oct; 62(7):938-43. PubMed ID: 25127435
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function.
Waschki B; Watz H; Holz O; Magnussen H; Olejnicka B; Welte T; Rabe KF; Janciauskiene S
Int J Chron Obstruct Pulmon Dis; 2017; 12():981-987. PubMed ID: 28356730
[TBL] [Abstract][Full Text] [Related]
15. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease.
Patel IS; Vlahos I; Wilkinson TM; Lloyd-Owen SJ; Donaldson GC; Wilks M; Reznek RH; Wedzicha JA
Am J Respir Crit Care Med; 2004 Aug; 170(4):400-7. PubMed ID: 15130905
[TBL] [Abstract][Full Text] [Related]
16. Chronic rhinosinusitis is associated with higher prevalence and severity of bronchiectasis in patients with COPD.
Yang X; Xu Y; Jin J; Li R; Liu X; Sun Y
Int J Chron Obstruct Pulmon Dis; 2017; 12():655-662. PubMed ID: 28260873
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Huang Q; Xiong H; Shuai T; Wang Y; Zhang C; Zhang M; Zhu L; Lu J; Liu J
Ther Adv Respir Dis; 2020; 14():1753466620938546. PubMed ID: 32643535
[TBL] [Abstract][Full Text] [Related]
19. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
Xiao W; Tong WL; Ma DD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
[TBL] [Abstract][Full Text] [Related]
20. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
